Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
11 - 18 out of 18Page size: 10
  1. 2003
  2. Published

    K65R with and withourt S68: A new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

    Røge, B., Katzenstein, T., Obel, N., Pedersen, C., Mathiesen, L. R., Lundgren, Jens & Gerstoft, J., 2003, In: Antiviral Therapy.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

    Gerstoft, J., Kirk, O., Obel, N., Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Modelling the three year risk of myocardial infarction among participants in the D:A:D study

    Law, M., Friis-Møller, N., Weber, R., Reiss, P., Thiebaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Calvo, G., El-Sadr, W., Wit, S. D., Sabin, C. & Lundgren, Jens, 2003, In: HIV Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Monitoring of long-term toxicities of HIV treatments: an international perspective

    Bisson, G., Gross, R., Miller, V., Weller, I., Walker, A., Arlett, P., Carr, A., Evans, S., Graham, D., Justice, A., Kreft-Jais, C., Lundgren, Jens, Munk, B., Murray, J., Pirmohamed, M., Pizutti, D. & Szarfman, A., 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

    Chene, G., Sterne, J., May, M., Costagliola, D., Ledergerber, B., Phillips, A., Dabis, F., Lundgren, Jens, Monforte, A. D., Wolf, F. D., Hogg, R., Reiss, P., Justice, A., Leport, C., Staszewski, S., Gill, J., Fätkenheuer, G. & Egger, M., 2003, In: Lancet.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.

    Dragsted, U. B., Gerstoft, J., Pedersen, C., Peters, B., Duran, A., Obel, N., Castagna, A., Cahn, P., Clumeck, N., Bruun, J. N., Benetucci, J., Hill, A., Cassetti, I., Vernazza, P., Youle, M., Fox, Z. & Lundgren, Jens, 2003, In: Journal of Infectious Diseases. 188, 5, p. 635-642 8 p.

    Research output: Contribution to journal › Journal article › Research

  8. Published

    Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited.

    Moore, A., Kirk, O., Johnson, A., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lundgren, Jens & Phillips, A., 2003, In: J A I D S.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Virological rebound after suppression o­n highly active antiretroviral therapy.

    Mocroft, A., Ruiz, L., Reiss, P., Ledergerber, B., Katlama, C., Lazzarin, A., Goebel, F., Phillips, A., Clotet, B. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 13961